文献速递心脑血管急症重症综合管理与镇静镇痛

重症创伤性脑损伤患者血浆胰岛素水平对深静脉血栓的预后意义

Prognostic Significance of Plasma Insulin Level for Deep Venous Thrombosis in Patients with Severe Traumatic Brain Injury in Critical Care.
PubMed 文献 · Neurocrit Care · 2022-09-16
一句话结论重症创伤性脑损伤后14天内胰岛素水平升高可能与胰岛素抵抗相关,并伴随血小板过度活跃,从而增加深静脉血栓风险。

这项前瞻性观察研究纳入73例重症创伤性脑损伤患者,在伤后14天内四个预设时间点测定胰岛素、血糖、胰高血糖素样肽1、炎症因子和血液学指标,并用超声追踪深静脉血栓。20例(27%)发生深静脉血栓,中位时间10.4天(范围4-22天)。接受胰岛素治疗者14天胰岛素水平更高,深静脉血栓发生率更高(60% vs 15%;P<0.001),且格拉斯哥结局量表评分更差(P=0.001)。年龄(P=0.01)和第4-7天胰岛素水平升高(P=0.04)与深静脉血栓独立相关。

要点

  • 重症创伤性脑损伤后14天内深静脉血栓发生率为27%(20/73),中位发生时间10.4天(范围4-22天)。
  • 接受胰岛素治疗的患者深静脉血栓发生率高于未接受胰岛素治疗者(60% vs 15%;P<0.001)。
  • 年龄(P=0.01)和第4-7天胰岛素水平升高(P=0.04)与深静脉血栓独立相关。
  • 有深静脉血栓的患者接受胰岛素治疗的比例高于无深静脉血栓者(60% vs 28%;P=0.012)。
  • 接受胰岛素治疗的患者格拉斯哥结局量表评分更差(P=0.001)。

适用人群与场景

  • 重症创伤性脑损伤患者,平均年龄53(±16)岁,伤后14天内接受监测。

研究设计与关键结果

  • 前瞻性观察研究纳入73例重症创伤性脑损伤患者,伤后14天内四个预设时间点测定胰岛素、血糖、胰高血糖素样肽1、炎症因子和血液学指标,超声追踪深静脉血栓。
  • 20例(27%)发生深静脉血栓,中位时间10.4天(范围4-22天);深静脉血栓患者急性生理与慢性健康评估II评分更高,但序贯器官衰竭评估评分和创伤性脑损伤严重程度相似。
  • 深静脉血栓患者接受胰岛素治疗的比例高于无深静脉血栓者(60% vs 28%;P=0.012),因此14天胰岛素水平更高;但在接受胰岛素治疗(n=27)和未接受胰岛素治疗(n=46)的亚组中,深静脉血栓与无深静脉血栓者的胰岛素水平相当。
  • 血小板指标可显著区分有无深静脉血栓;凝血指标、血细胞计数和炎症介质在两组间均无差异。
  • 接受胰岛素治疗的患者胰岛素(P=0.006)、血糖(P<0.001)和胰高血糖素样肽1(P=0.01)水平显著更高,更易发生深静脉血栓(60% vs 15%;P<0.001),并伴血小板减少。
  • 胰岛素水平仅在无深静脉血栓患者中与血糖、胰高血糖素样肽1水平和血小板计数相关;在有深静脉血栓患者中,胰岛素与胰高血糖素样肽1水平呈负相关(P=0.016)。
  • 年龄(P=0.01)和第4-7天胰岛素水平升高(P=0.04)与深静脉血栓独立相关。
  • 接受胰岛素治疗的患者格拉斯哥结局量表评分更差(P=0.001)。

证据类型、等级与局限

  • 证据类型:前瞻性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,创伤性脑损伤后14天内胰岛素水平升高可能提示胰岛素抵抗,与血小板过度活跃相关,从而增加深静脉血栓风险。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Whether insulin resistance underlies deep venous thrombosis (DVT) development in patients with severe traumatic brain injury (TBI) is unclear. In this study, the association between plasma insulin levels and DVT was analyzed in patients with severe TBI.

METHODS: A prospective observational study of 73 patients measured insulin, glucose, glucagon-like peptide 1 (GLP-1), inflammatory factors, and hematological profiles within four preset times during the first 14 days after TBI. Ultrasonic surveillance of DVT was tracked. Two-way analysis of variance was used to determine the factors that discriminated between patients with and without DVT or with and without insulin therapy. Partial correlations of insulin level with all the variables were conducted separately in patients with DVT or patients without DVT. Factors associated with DVT were analyzed by multivariable logistic regression. Neurological outcomes 6 months after TBI were assessed.

RESULTS: Among patients with a mean (± standard deviation) age of 53 (± 16 years), DVT developed in 20 patients (27%) on median 10.4 days (range 4-22), with higher Acute Physiology and Chronic Health Evaluation II scores but similar Sequential Organ Failure Assessment scores and TBI severity. Patients with DVT were more likely to receive insulin therapy than patients without DVT (60% vs. 28%; P = 0.012); hence, they had higher 14-day insulin levels. However, insulin levels were comparable between patients with DVT and patients without DVT in the subgroups of patients with insulin therapy (n = 27) and patients without insulin therapy (n = 46). The platelet profile significantly discriminated between patients with and without DVT. Surprisingly, none of the coagulation profiles, blood cell counts, or inflammatory mediators differed between the two groups. Patients with insulin therapy had significantly higher insulin (P = 0.006), glucose (P < 0.001), and GLP-1 (P = 0.01) levels and were more likely to develop DVT (60% vs. 15%; P < 0.001) along with concomitant platelet depletion. Insulin levels correlated with glucose, GLP-1 levels, and platelet count exclusively in patients without DVT. Conversely, in patients with DVT, insulin correlated negatively with GLP-1 levels (P = 0.016). Age (P = 0.01) and elevated insulin levels at days 4-7 (P = 0.04) were independently associated with DVT. Patients with insulin therapy also showed worse Glasgow Outcome Scale scores (P = 0.001).

CONCLUSIONS: Elevated insulin levels in the first 14 days after TBI may indicate insulin resistance, which is associated with platelet hyperactivity, and thus increasing the risk of DVT.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Du M, Zhang QH, Tang R, et al. Prognostic Significance of Plasma Insulin Level for Deep Venous Thrombosis in Patients with Severe Traumatic Brain Injury in Critical Care. Neurocrit Care. 2022. PMID: 36114315. doi:10.1007/s12028-022-01588-y

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。